Oculis Holding AG (OCS) Cash from Financing Activities (2022 - 2026)

Oculis Holding AG (OCS) recorded quarterly Cash from Financing Activities of $30.1 million in Q1 2026, down 71.39% quarter-over-quarter from $105.3 million in Q4 2025, and down 73.9% on a YoY basis from $115.5 million in Q1 2025.

Oculis Holding AG (OCS) Cash from Financing Activities (2022 - 2026) Analysis & Trends

Oculis Holding AG's Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $30.1 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 73.9% year-over-year to $30.1 million; the TTM figure through Mar 2026 stood at $134.1 million (down 23.41% YoY), while the FY2025 annual figure was $233.9 million, up 279.56% from the prior year.
  • Cash from Financing Activities was $30.1 million for Q1 2026 at Oculis Holding AG, down from $105.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $115.5 million in Q1 2025 to a low of -$2.1 million in Q3 2025.
  • Historically, Cash from Financing Activities has averaged $30.2 million across 5 years, with a median of $2.0 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities sank 264.05% in 2024, then surged 58848.04% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$288570.1 in 2022, then surged by 264.08% to $473488.9 in 2023, then surged by 549.73% to $3.1 million in 2024, then surged by 3324.12% to $105.3 million in 2025, then slumped by 71.39% to $30.1 million in 2026.
  • The last three Cash from Financing Activities figures came in at $30.1 million (Q1 2026), $105.3 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 7.00 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -600,000.00
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 53,000.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -538.80 Mn
9 Abivax 90.15 Bn 90.15 Bn - 85,464.43
10 Oculis Holding AG 8.23 Bn 7.92 Bn - 30.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.14 Mn
Mar 31, 2026 30.14 Mn
Dec 31, 2025 105.34 Mn
Dec 31, 2025 105.34 Mn
Sep 30, 2025 -2.14 Mn
Sep 30, 2025 -2.14 Mn
Jun 30, 2025 730,773.59
Jun 30, 2025 730,773.59
Mar 31, 2025 115.49 Mn
Mar 31, 2025 115.49 Mn
Dec 31, 2024 3.08 Mn
Dec 31, 2024 3.08 Mn
Sep 30, 2024 -850,650.74
Sep 30, 2024 -850,650.74
Jun 30, 2024 57.33 Mn
Jun 30, 2024 57.33 Mn
Mar 31, 2024 195,911.68
Mar 31, 2024 195,911.68
Dec 31, 2023 473,488.88
Dec 31, 2023 473,488.88